Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.
- DOI
- 10.1002/cam4.2865
- Published
- 2020 May
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.2865,
title = {Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.},
author = {Gill H and Yim R and Pang HH and Lee P and Chan TSY and Hwang YY and Leung GMK and Ip HW and Leung RYY and Yip SF and Kho B and Lee HKK and Mak V and Chan CC and Lau JSM and Lau CK and Lin SY and Wong RSM and Li W and Ma ESK and Li J and Panagiotou G and Sim JPY and Lie AKW and Kwong YL},
year = {2020},
journal = {Cancer medicine},
doi = {10.1002/cam4.2865},
url = {https://doi.org/10.1002/cam4.2865}
}RIS
TY - JOUR TI - Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation. AU - Gill H AU - Yim R AU - Pang HH AU - Lee P AU - Chan TSY AU - Hwang YY AU - Leung GMK AU - Ip HW AU - Leung RYY AU - Yip SF AU - Kho B AU - Lee HKK AU - Mak V AU - Chan CC AU - Lau JSM AU - Lau CK AU - Lin SY AU - Wong RSM AU - Li W AU - Ma ESK AU - Li J AU - Panagiotou G AU - Sim JPY AU - Lie AKW AU - Kwong YL PY - 2020 JO - Cancer medicine DO - 10.1002/cam4.2865 UR - https://doi.org/10.1002/cam4.2865 ER -
APA
H, G., R, Y., HH, P., P, L., TSY, C., YY, H., GMK, L., HW, I., RYY, L., SF, Y., B, K., HKK, L., V, M., CC, C., JSM, L., CK, L., SY, L., RSM, W., W, L., ESK, M., J, L., G, P., JPY, S., AKW, L., & YL, K. (2020). Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.. Cancer medicine. https://doi.org/10.1002/cam4.2865
Source records
- pubmed · retrieved 2026-09-27T11:20:12.453Z